The enterprise flash storage market, valued at USD 23.71 billion in 2025, is forecast to nearly double by 2034, expanding at a CAGR of 8.16%. Engineered for speed and security, solutions such as all-flash arrays, NVMe storage, and persistent memory are fast becoming the backbone of data-driven enterprises. Key growth drivers include surging demand for real-time […]
The global intelligent platform management interface market registered a size of USD 1.27 billion in 2024 and is projected to surge to USD 2.88 billion by 2034, manifesting a CAGR of 8.54% from 2025 to 2034. This positive momentum is powered by expanding data center deployments, surging remote server management demand, and the critical need
RNA Editing for Neurodegenerative Diseases Market Companies ADARx Pharmaceuticals Amber Bio Ascidian Therapeutics Beam Therapeutics Eli Lilly & Co. GSK Plc Korro Bio Moderna Inc. ProQR Therapeutics Roche Holding AG Shape Therapeutics Takeda Pharmaceutical Company Verve Therapeutics Wave Life Sciences Regeneron Pharmaceuticals Download Sample Report ADARx Pharmaceuticals Company Name and Headquarters: ADARx Pharmaceuticals, Inc. – San
AI-Driven Drug Discovery Platforms Market Companies Atomwise BenevolentAI Cloud Pharmaceuticals DeepMind (Alphabet) Exscientia Healx Insilico Medicine LabGenius Numerate Owkin Recursion Pharmaceuticals Relay Therapeutics Schrödinger Valo Health twoXa Download Sample Report Atomwise Company Name and Headquarters: Atomwise Inc., San Francisco, CA, USA Product Offerings: AtomNet® platform, an AI-powered drug discovery platform that uses deep convolutional neural networks to
Smart Retinal Implants Market Companies Second Sight Medical Products, Inc. Retina Implant AG Pixium Vision SA Bionic Vision Technologies Nano Retina, Inc. Intelligent Implants GmbH iBionics Optobionics Corporation VisionCare Ophthalmic Technologies Ocumetics Technology Corporation Nidek Co., Ltd. Boston Scientific Corporation Medtronic plc Alcon (Novartis) Johnson & Johnson Vision Care, Inc. Zeiss Group Ophthorobotics AG Gensight
Rare Musculoskeletal Disorder Treatments Market Companies Astellas Amgen AstraZeneca BioMarin Pharmaceutical Eli Lilly Fujifilm/possible CDMOs (manufacturing partners) Ionis Pharmaceuticals Novartis Pfizer PTC Therapeutics Regenxbio Sarepta Therapeutics Sanofi Takeda Cytokinetics Download Sample Report Astellas Pharma Inc. Headquarters: Tokyo, Japan Product Offerings related to Rare Musculoskeletal Disorder Treatments: While Astellas is a major pharmaceutical company with a broad portfolio,
RNA Editing Therapies Market Companies ADARx Pharmaceuticals Amber Bio Ascidian Therapeutics Beam Therapeutics Catalent GSK Korro Bio Moderna ProQR Therapeutics Regenxbio Roche Shape Therapeutics Wave Life Sciences ADAPTABLE CDMO / specialized oligo CDMOs Smaller specialist startups & platform players Download Sample Report ADARx Pharmaceuticals Company Name and Headquarters: ADARx Pharmaceuticals, Inc. (San Diego, California, USA) Product
Background The semiconductor industry has rapidly shifted from traditional packaging methods (like wire bonding and flip-chip) to advanced forms such as 2.5D/3D integration, fan-out wafer-level packaging, and heterogeneous integration. While much attention is given to silicon, interposers, and interconnects, the “soft side” of packaging — polymer-based materials like underfills, die attach adhesives, encapsulants, mold compounds,
Tesla’s shares climbed over 3% on Monday, closing at $410.26, after CEO Elon Musk purchased more than 2.5 million shares valued at roughly $1 billion. The acquisition, revealed in a regulatory filing, was executed across multiple transactions on Friday. The rally boosted Tesla’s market capitalization to $1.28 trillion, reinforcing investor confidence in the electric vehicle
The global multi-tenant data centers market size stood at USD 56.10 billion in 2024 and is projected to surge to approximately USD 189.59 billion by 2034, growing at a robust CAGR of 12.95% from 2025 to 2034. This rapid growth is propelled by booming demand for cost-efficient, scalable IT infrastructure, accelerating adoption of cloud computing,
